Yin-Dan-Ping-Gan Capsule Mitigates CCL₄-Induced Liver Fibrosis via Regulating PPAR γ/GPX4 Signaling and Suppressing Ferroptosis

<b>Background:</b> Liver fibrosis is a major global public health issue that is only getting worse. The underlying molecular mechanisms of Yindanpinggan Capsule (YDPG), a traditional Chinese medication, are still unknown, although it has shown notable effectiveness in treating fibrosis and other for...

Descripció completa

Dades bibliogràfiques

Autors principals:	Xue Jiang, Jicheng Yang, Yusheng Zhang, Ying Zhang, Zhen Ouyang, Chen Zhao, Limin Lin, Xianyu Li, Luqi Huang
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2026-02-01
Col·lecció:	Pharmaceuticals
Matèries:	Yindanpinggan Capsule liver fibrosis network pharmacology proteomics ferroptosis PPAR γ
Accés en línia:	https://www.mdpi.com/1424-8247/19/2/251
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!